176 related articles for article (PubMed ID: 34353648)
1. Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients With Moderate to Severe Alcohol Use Disorder: Feasibility and Initial Outcomes.
Anderson ES; Chamberlin M; Zuluaga M; Ullal M; Hawk K; McCormack R; D'Onofrio G; Herring AA
Ann Emerg Med; 2021 Dec; 78(6):752-758. PubMed ID: 34353648
[TBL] [Abstract][Full Text] [Related]
2. Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler.
Kranzler HR
Drugs; 2006; 66(13):1753-4. PubMed ID: 16978038
[No Abstract] [Full Text] [Related]
3. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
[TBL] [Abstract][Full Text] [Related]
4. Implementation and analysis of a multifaceted intervention for alcohol use disorder from a single academic urban emergency department.
Duvalyan E; Falade I; Fan W; Foe M; Mvemba A; Zussman JW; Geier C; LeSaint KT; Graglia S
Acad Emerg Med; 2024 May; 31(5):456-462. PubMed ID: 38380769
[TBL] [Abstract][Full Text] [Related]
5. Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON).
Malone M; McDonald R; Vittitow A; Chen J; Obi R; Schatz D; Tofighi B; Garment A; Kermack A; Goldfeld K; Gold H; Laska E; Rotrosen J; Lee JD
Contemp Clin Trials; 2019 Jun; 81():102-109. PubMed ID: 30986535
[TBL] [Abstract][Full Text] [Related]
6. Extended-release intramuscular naltrexone.
Swainston Harrison T; Plosker GL; Keam SJ
Drugs; 2006; 66(13):1741-51. PubMed ID: 16978037
[TBL] [Abstract][Full Text] [Related]
7. Extended-Release Naltrexone and Case Management for Treatment of Alcohol Use Disorder in the Emergency Department.
Murphy CE; Coralic Z; Wang RC; Montoy JCC; Ramirez B; Raven MC
Ann Emerg Med; 2023 Apr; 81(4):440-449. PubMed ID: 36328851
[TBL] [Abstract][Full Text] [Related]
8. Commentary on Murphy et al.: What will it take to prescribe extended-release naltrexone to treat alcohol use disorder?
Springer SA
Addiction; 2022 Feb; 117(2):282-283. PubMed ID: 34549844
[No Abstract] [Full Text] [Related]
9. Extended-release intramuscular naltrexone: a viewpoint by Falk Kiefer.
Kiefer F
Drugs; 2006; 66(13):1752-3. PubMed ID: 16978039
[No Abstract] [Full Text] [Related]
10. Comparison of healthcare utilization among patients treated with alcoholism medications.
Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.
Korthuis PT; Lum PJ; Vergara-Rodriguez P; Ahamad K; Wood E; Kunkel LE; Oden NL; Lindblad R; Sorensen JL; Arenas V; Ha D; Mandler RN; McCarty D;
Addiction; 2017 Jun; 112(6):1036-1044. PubMed ID: 28061017
[TBL] [Abstract][Full Text] [Related]
12. Patient perspectives on emergency department initiation of medication for alcohol use disorder.
Forsgren E; Steiger A; Perez Y; Salazar D; McCollough M; Taira BR
Acad Emerg Med; 2024 May; 31(5):471-480. PubMed ID: 37326129
[TBL] [Abstract][Full Text] [Related]
13. Predischarge Injectable Versus Oral Naltrexone to Improve Postdischarge Treatment Engagement Among Hospitalized Veterans with Alcohol Use Disorder: A Randomized Pilot Proof-of-Concept Study.
Busch AC; Denduluri M; Glass J; Hetzel S; Gugnani SP; Gassman M; Krahn D; Deyo B; Brown R
Alcohol Clin Exp Res; 2017 Jul; 41(7):1352-1360. PubMed ID: 28605827
[TBL] [Abstract][Full Text] [Related]
14. Extended-release intramuscular naltrexone: a viewpoint by Steven Siegel.
Siegel S
Drugs; 2006; 66(13):1752. PubMed ID: 16978040
[No Abstract] [Full Text] [Related]
15. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders.
Chokron Garneau H; Venegas A; Rawson R; Ray LA; Glasner S
J Subst Abuse Treat; 2018 Feb; 85():34-37. PubMed ID: 28527854
[TBL] [Abstract][Full Text] [Related]
16. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.
Springer SA; Altice FL; Herme M; Di Paola A
Contemp Clin Trials; 2014 Mar; 37(2):209-18. PubMed ID: 24384538
[TBL] [Abstract][Full Text] [Related]
17. Extended-release naltrexone for treatment of alcohol dependence in primary care.
Lee JD; Grossman E; DiRocco D; Truncali A; Hanley K; Stevens D; Rotrosen J; Gourevitch MN
J Subst Abuse Treat; 2010 Jul; 39(1):14-21. PubMed ID: 20363090
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
[TBL] [Abstract][Full Text] [Related]
19. Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients.
Pettinati HM; Gastfriend DR; Dong Q; Kranzler HR; O'Malley SS
Alcohol Clin Exp Res; 2009 Feb; 33(2):350-6. PubMed ID: 19053979
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal.
Stephens JR; Moore C; Stepanek KV; Garbutt JC; Starke B; Liles A; Jonas DE
J Hosp Med; 2018 Apr; 13(4):221-228. PubMed ID: 29364992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
